Has Tomasz Chec, MD received payments from drug or device companies?

Yes. Drug and device makers reported $114 in general payments to Tomasz Chec, MD across 7 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tomasz Chec, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tomasz Chec, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tomasz Chec, MD

Physical Medicine & Rehabilitation · Philadlephia, PANPI 1326400474

Payments from drug & device makers

$114in general payments, 2019–2025

Across 7 payments — averaging $16.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$30
Bioventus LLC$27
Heraeus Medical, LLC.$17
Kowa Pharmaceuticals America, Inc.$14
Medtronic$14
Saol Therapeutics Inc.$13

What the payments were for

Food & beverage$114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	2	$30
Bioventus LLC	1	$27
Heraeus Medical, LLC.	1	$17
Kowa Pharmaceuticals America, Inc.	1	$14
Medtronic	1	$14
Saol Therapeutics Inc.	1	$13

How this compares

$114 in reported general payments places this provider in the 40th percentile of 550 physical medicine & rehabilitation providers in Pennsylvania.

See all physical medicine & rehabilitation providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$269,303

Medicare patients

776

Services billed

9,013

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	341	$4,039
Pregabalin	80	$1,550
Lidocaine	12	$639
Tramadol Hcl	73	$561
Methylprednisolone	90	$531
Meloxicam	128	$368
Acetaminophen-CodeineAcetaminophen With Codeine	25	$214
Tizanidine Hcl	18	$193
Cyclobenzaprine Hcl	29	$149
Diazepam	11	$7

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Philadlephia

Cameron OlezenePhiladelphia$4.1M
Jeffery RoweKing Of Prussia$2M
Michael SaulinoElkins Park$502K
Alberto EsquenaziPhiladelphia$465K
Huaguang QuChalfont$426K
Michael MuninPittsburgh$412K
Scott DavidoffKing Of Prussia$365K
Mitchell PaulinPaoli$229K
Natasha RomanoskiHummelstown$139K
Kimberly HeckertPhiladelphia$119K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →